| Primary |
| Stress Echocardiography |
34.4% |
| Cardiac Stress Test |
15.6% |
| Intentional Use For Unlabeled Indication |
15.6% |
| Cerebral Vasoconstriction |
6.3% |
| Septic Shock |
6.3% |
| Stress Echocardiogram |
6.3% |
| Vasospasm |
6.3% |
| Angina Pectoris |
3.1% |
| Exertional Dyspnea |
3.1% |
| Product Used For Unknown Indication |
3.1% |
|
| Chest Pain |
20.8% |
| Stress Cardiomyopathy |
20.8% |
| Ventricular Extrasystoles |
12.5% |
| Drug Ineffective |
8.3% |
| Medication Error |
8.3% |
| Ventricular Arrhythmia |
8.3% |
| Cardiogenic Shock |
4.2% |
| Mitral Valve Disease |
4.2% |
| Product Commingling |
4.2% |
| Product Quality Issue |
4.2% |
| Subarachnoid Haemorrhage |
4.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
25.0% |
| Stress Echocardiography |
12.8% |
| Pulmonary Hypertension |
9.6% |
| Mean Arterial Pressure |
7.7% |
| Product Used For Unknown Indication |
7.7% |
| Intentional Use For Unlabeled Indication |
6.4% |
| Ejection Fraction Decreased |
5.1% |
| Adrenocortical Insufficiency Acute |
4.5% |
| Stress Echocardiogram |
3.8% |
| Induction Of Anaesthesia |
2.6% |
| Pain |
2.6% |
| Anaphylactic Shock |
1.9% |
| Echocardiogram |
1.9% |
| Prophylaxis |
1.9% |
| Shock |
1.9% |
| Allogenic Bone Marrow Transplantation Therapy |
1.3% |
| Immunosuppression |
1.3% |
| Bronchopulmonary Aspergillosis |
0.6% |
| Capd |
0.6% |
| Congestive Cardiomyopathy |
0.6% |
|
| Chest Pain |
23.8% |
| Eosinophilic Myocarditis |
9.5% |
| Toxic Epidermal Necrolysis |
7.1% |
| Ventricular Tachycardia |
7.1% |
| Cardio-respiratory Arrest |
4.8% |
| Death |
4.8% |
| Drug Ineffective |
4.8% |
| Medication Error |
4.8% |
| Stress Cardiomyopathy |
4.8% |
| Tricuspid Valve Incompetence |
4.8% |
| Atrioventricular Block Complete |
2.4% |
| Cardiac Failure Congestive |
2.4% |
| Cardiogenic Shock |
2.4% |
| Myoclonus |
2.4% |
| Nausea |
2.4% |
| Oedema |
2.4% |
| Oedema Mouth |
2.4% |
| Overdose |
2.4% |
| Portal Vein Thrombosis |
2.4% |
| Product Commingling |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
55.9% |
| Drug Use For Unknown Indication |
19.7% |
| Cardiac Failure |
3.3% |
| Coronary Artery Bypass |
3.2% |
| Prophylaxis |
2.2% |
| Hypertension |
1.9% |
| Pulmonary Arterial Hypertension |
1.5% |
| Haemodynamic Instability |
1.2% |
| Acute Coronary Syndrome |
1.1% |
| Sedation |
1.1% |
| Viral Infection |
1.0% |
| Cardiogenic Shock |
1.0% |
| Polyuria |
1.0% |
| Hypotension |
0.9% |
| Convulsion |
0.9% |
| Atrial Fibrillation |
0.8% |
| Grand Mal Convulsion |
0.8% |
| Pneumonia |
0.8% |
| Status Epilepticus |
0.8% |
| Catheterisation Cardiac |
0.8% |
|
| Thrombocytopenia |
10.4% |
| Injury |
8.4% |
| Sepsis |
7.1% |
| Platelet Count Decreased |
5.8% |
| Renal Failure |
5.8% |
| Renal Failure Acute |
5.8% |
| Unevaluable Event |
5.8% |
| Pain |
5.2% |
| Vomiting |
5.2% |
| Anhedonia |
4.5% |
| Cardiac Failure |
4.5% |
| Fear |
4.5% |
| Rhabdomyolysis |
3.9% |
| Ventricular Tachycardia |
3.9% |
| Hypotension |
3.2% |
| Multi-organ Failure |
3.2% |
| Respiratory Failure |
3.2% |
| Stress |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Cardiac Failure Acute |
2.6% |
|
